Thursday, August 25, 2016 4:36:36 PM
http://www.nanoviricides.com/press%20releases/2014/NanoViricides%20Inc.%20Celebrated%20the%20Grand%20Opening%20of%20Its%20New%20R&D%20and%20cGMP%20Pilot%20Manufacturing%20Facility%20with%20Congressman%20Jim%20Himes%20as%20the%20Chief%20Guest%20Yesterday.html
More recently the State's other US Senator, Richard Blumenthal, got the grand tour. His visit coincided with a different cataclysmic pestilence posing a threat to mankind, ebola, during NanoViricides unsuccessful efforts to save the world with ebolacide.
"The Shelton facility is large enough that it could be used for larger-scale manufacturing. “Quantity production needed to curb the current [Ebola] outbreak can be performed readily in our new facility,” according to NanoViricides material."
http://www.sheltonherald.com/56772/shelton-firm-is-on-frontlines-of-ebola-researchebola/
And now:
"Dr. Diwan stressed that finding a clinically viable drug candidate against the Zika virus could take as little as three to six months, leveraging upon the Company's broad-spectrum dengue drug development work, if a virus-binding ligand from our anti-dengue library works against the Zika virus."
http://www.prnewswire.com/news-releases/nanoviricides-reports-on-senator-murphys-visit-to-the-companys-shelton-campus-300318153.html
A legacy of carrots.
"Name a disease, the more horrifying the better, and we assure you that we will promise to attempt to create a drug to treat it".
Ralph Wiggum: I cheated wrong. I copied the Lisa name and used the Ralph answers.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM